While Rep. Marsha Blackburn's most recent version of the SOFTWARE Act reduces criteria FDA could consider when deciding if a health IT software should be regulated compared to previous versions it still gives the agency overarching authority to determine what health software poses higher risk to patients which has some experts conflicted over its significance.
Three days before the House Energy and Commerce Subcommittee unanimously approved the 21st Century Cures bill that includes the measure, Blackburn released a revised version of the Sensible...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?